Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors
Prostate cancer (PCa) is the second most common cancer in men. Androgen deprivation therapy (ADT) leads to tumor involution and reduction of tumor burden. However, tumors eventually reemerge that have overcome the absence of gonadal androgens, termed castration resistant PCa (CRPC). Theories underly...
Main Authors: | Mostaghel, Elahe A., Solomon, Keith R., Pelton, Kristine, Freeman, Michael R., Montgomery, R. Bruce |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261168/ |
Similar Items
-
The Response of the Prostate to Circulating Cholesterol: Activating Transcription Factor 3 (ATF3) as a Prominent Node in a Cholesterol-Sensing Network
by: Kim, Jayoung, et al.
Published: (2012) -
Correction: The Response of the Prostate to Circulating Cholesterol: Activating Transcription Factor 3 (ATF3) as a Prominent Node in a Cholesterol-Sensing Network
by: Kim, Jayoung, et al.
Published: (2012) -
Glucocorticoids and prostate cancer treatment: friend or foe?
by: Montgomery, Bruce, et al.
Published: (2014) -
Beyond T and DHT - Novel Steroid Derivatives Capable of Wild Type Androgen Receptor Activation
by: Mostaghel, Elahe A
Published: (2014) -
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Mostaghel, Elahe A
Published: (2014)